138 related articles for article (PubMed ID: 34141777)
1. Why
Huang YJ; Cao ZF; Wang J; Yang J; Wei YJ; Tang YC; Cheng YX; Zhou J; Zhang ZX
World J Clin Cases; 2021 Jun; 9(17):4143-4158. PubMed ID: 34141777
[TBL] [Abstract][Full Text] [Related]
2. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract][Full Text] [Related]
3. Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer.
Zhang F; Li X; Chen H; Guo J; Xiong Z; Yin S; Jin L; Chen X; Luo D; Tang H; Mao C; Lian L
Front Med (Lausanne); 2022; 9():836892. PubMed ID: 35211490
[TBL] [Abstract][Full Text] [Related]
4. Effect of
Wang Z; Hou H; Zhang H; Duan X; Li L; Meng L
Am J Transl Res; 2022; 14(2):849-862. PubMed ID: 35273689
[TBL] [Abstract][Full Text] [Related]
5. Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
Zhang L; Han X; Shi Y
JAMA Netw Open; 2020 Aug; 3(8):e2013201. PubMed ID: 32845327
[TBL] [Abstract][Full Text] [Related]
6. High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring
Wang Q; Yang Y; Yang M; Li X; Chen K
Aging (Albany NY); 2020 Jun; 12(11):10827-10843. PubMed ID: 32491995
[TBL] [Abstract][Full Text] [Related]
7. MUC16 mutations improve patients' prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer microenvironment.
Hu J; Sun J
Oncoimmunology; 2018; 7(10):e1487914. PubMed ID: 30288353
[TBL] [Abstract][Full Text] [Related]
8. MUC16 mutation predicts a favorable clinical outcome and correlates decreased Warburg effect in gastric cancer.
Zhao H; Zhang L
Biochem Biophys Res Commun; 2018 Dec; 506(4):780-786. PubMed ID: 30389134
[TBL] [Abstract][Full Text] [Related]
9. The Association of
Wang X; Yu X; Krauthammer M; Hugo W; Duan C; Kanetsky PA; Teer JK; Thompson ZJ; Kalos D; Tsai KY; Smalley KSM; Sondak VK; Chen YA; Conejo-Garcia JR
Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1792-1799. PubMed ID: 32611582
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
Liu B; Dong Z; Lu Y; Ma J; Ma Z; Wang H
Evid Based Complement Alternat Med; 2022; 2022():3478861. PubMed ID: 36034941
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response.
Wang H; Yan C; Ye H
Exp Ther Med; 2020 Aug; 20(2):1725-1733. PubMed ID: 32765681
[TBL] [Abstract][Full Text] [Related]
12. Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer.
Zhao DY; Sun XZ; Yao SK
World J Gastrointest Oncol; 2021 Jan; 13(1):37-57. PubMed ID: 33510848
[TBL] [Abstract][Full Text] [Related]
13. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
Kang K; Xie F; Mao J; Bai Y; Wang X
Front Oncol; 2020; 10():573141. PubMed ID: 33072607
[No Abstract] [Full Text] [Related]
14. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Analysis Based on TCGA: MUC16 Mutation Correlates with Clinical Outcome in Gastric Cancer.
Huang L; Zheng S; Fu J; Zhang M; Ge X; Mu N
Dis Markers; 2022; 2022():6734105. PubMed ID: 36051359
[TBL] [Abstract][Full Text] [Related]
16. Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment.
Wang X; Duanmu J; Fu X; Li T; Jiang Q
J Transl Med; 2020 Aug; 18(1):324. PubMed ID: 32859214
[TBL] [Abstract][Full Text] [Related]
17. An Analysis Regarding the Association Between the
Li S; Zhao W; Sun M
Front Genet; 2020; 11():620. PubMed ID: 32612640
[TBL] [Abstract][Full Text] [Related]
18. Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma.
Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Otsuka S; Ohnami S; Nagashima T; Hatakeyama K; Sugino T; Urakami K; Akiyama Y; Yamaguchi K
BMC Cancer; 2022 Oct; 22(1):1046. PubMed ID: 36199046
[TBL] [Abstract][Full Text] [Related]
19.
Kanwal M; Ding XJ; Song X; Zhou GB; Cao Y
Oncotarget; 2018 Feb; 9(15):12226-12239. PubMed ID: 29552305
[TBL] [Abstract][Full Text] [Related]
20. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
[Next] [New Search]